Related Experiment Videos
Watch for ICE in neurodegeneration
1Parke-Davis Pharmaceutical Research, Division of Warner-Lambert, Ann Arbor, MI 48105, USA.
Molecular Psychiatry
|March 1, 1996
Summary
Neuronal death involves apoptosis and programmed cell death. ICE homologs, cysteine proteases, are potential mediators, suggesting antagonists may offer neuroprotection in neurodegenerative diseases.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Neuronal death is a natural process during development and a response to injury.
- Cell death mechanisms include necrosis, apoptosis, and programmed cell death.
- Interleukin-1 beta converting enzyme (ICE) is a key cysteine protease involved in necrosis and apoptosis.
Purpose of the Study:
- To investigate the role of ICE family members in neuronal death.
- To explore the potential of ICE antagonists as neuroprotective agents.
Main Methods:
- Review of existing literature on ICE, apoptosis, and neuronal death.
- Analysis of ICE expression and function in neuronal cells.
- Examination of pharmacological inhibition of apoptosis and programmed cell death.
Main Results:
- ICE itself is not directly expressed in neurons, making it unlikely to directly mediate neuronal death.
- ICE homologs, however, are present in neurons and may mediate apoptosis and programmed cell death.
- Pharmacological inhibition of apoptosis and programmed cell death in vitro and during development supports the role of ICE homologs.
Conclusions:
- ICE homologs are potential mediators of apoptosis and programmed cell death in neurons.
- Antagonists targeting this protease family may offer neuroprotection against neurodegenerative diseases with apoptotic components.